Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance

Journal of Health Economics

Volumn 27, Issue 6, 2008, Pages 1407-1417

  Pauly, Mark V ^a   Blavin, Fredric E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Health insurance; Moral hazard; Value based cost sharing

Indexed keywords

ECONOMETRICS; HEALTH INSURANCE; HEALTH POLICY; HEALTH SERVICES; MORALITY; NUMERICAL MODEL;

ARTICLE; COST; HAZARD ASSESSMENT; HEALTH INSURANCE; MEDICAL INFORMATION;

CONSUMER PARTICIPATION; COST SHARING; HEALTH SERVICES NEEDS AND DEMAND; INSURANCE, HEALTH; MODELS, THEORETICAL; UNITED STATES;

EID: 55149084795     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2008.07.003     Document Type: Article

References (18)

1. Braithwaite R.S., and Rosen A.B. Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Annals of Internal Medicine 146 (2007) 602-605
2. Catlin A., Cowan C., Hartman M., and Heffler S. National health spending in 2006: a year of change for prescription drugs. National Health Expenditure Accounts Team. Health Affairs 27 1 (2008) 14-29
3. Chernew M.E., Rosen A., and Fendrick A.M. Value-based insurance design. Health Affairs 26 2 (2007) w195-w203
4. Fendrick A.M., and Chernew M.E. Value-based insurance design: a 'clinically sensitive' approach to preserve quality and contain costs. American Journal of Managed Care 12 1 (2006) 18-20
5. Fendrick A.M., Smith D.G., Chernew M.E., and Shahet S.N. Benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. American Journal of Managed Care 7 9 (2001) 861-869
6. Goldman D.P., Joyce G.F., Escarce J.J., Pace J.E., Solomon M.D., Laouri M., Landsman P.B., and Teutsch S.M. Pharmacy benefits and the use of drugs by the chronically ill. Journal of the American Medical Association 291 19 (2004) 2344-2350
7. Jack W., and Sheiner L. Welfare-improving health expenditure subsidies. American Economic Review 87 2 (1997) 206-221
8. Kent D.M., and Hayward R.A. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. Journal of the American Medical Association 298 10 (2007) 1209-1212
9. McGlynn E.A., Asch S.M., Adams J., Keesey J., Hicks J., DeCristofaro A., and Kerr E.A. The quality of health care delivered to adults in the United States. New England Journal of Medicine 348 26 (2003) 2635-2645
10. Newhouse J.P. Reconsidering the moral hazard-risk avoidance tradeoff. Journal of Health Economics 25 5 (2006) 1005-1014
11. Newhouse J.P., and Insurance Experiment Group. Free for all? Lessons from the RAND health insurance experiment (1993), Harvard University Press, Cambridge, MA
12. Pauly M.V. The economics of moral hazard. American Economic Review 58 3 (1968) 531-537
13. Pauly M.V. Forthcoming. Adverse selection and moral hazard: implications for health insurance markets. In: Sloan F., and Kasper H. (Eds). Incentives and Choice in Health and Health Care (2008), MIT Press, Cambridge, MA
14. Pauly M.V., and Held P.J. Benign moral hazard and the cost-effectiveness analysis of insurance coverage. Journal of Health Economics 9 4 (1990) 447-461
15. Phelps C.E. Health Economics. 3rd ed. (2003), Addison Wesley, Boston
16. Spiegel B.M.R., Targownik L., Dulai G.S., and Gralnek I.M. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis. Annals of Internal Medicine 138 10 (2003) 1-39
17. Trivedi A., Rakowski W., and Ayanian J. Effect of cost sharing on screening mammography in medicare health plans. New England Journal of Medicine 358 4 (2008) 375-383
18. Zeckhauser R.J. Medical insurance: a case study of the tradeoff between risk spreading and appropriate incentives. Journal of Economic Theory 2 1 (1970) 10-26